2 approvals in less than 1 year - Mitarbeiter (anonym) bei Genentech: Mitarbeiterbewertung

4,0
1. März 2013
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Strong Pipeline -- received two FDA approvals in less than 1 year for Perjeta and Kadcyla. Company takes the time to celebrate success.

Kontras

There is a lot of work to be done. A local news broadcast advertised hiring 600 positions to bridge that gap.

Mehr Bewertungen zu Genentech entdecken

5,0
27. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Patient-centric company. great culture & benefits

Kontras

Not always clear how promotions are awarded.

2,0
19. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

The work is meaningful and overall the company vision aligns with my goals

Kontras

QA management has become inept. None of the leadership (aside from maybe one or two) truly understand the nuances of our site and jobs. They refuse to pay you more due to "budget" reasons but won't provide much information, they claim to be transparent but will make decisions behind your back and not communicate them, even if they impact you and/or your job. Leadership doesn't listen to feedback and gets defensive if you even try to give any. It honestly has become a game of politics only in QA and that's not really building any real quality culture.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle